Systematic versus selective heparin use to prevent radial artery occlusion after catheterization
Official title: Comparaison d'un Traitement systématique à l'héparine Versus sélectif Pour la prévention de l'Occlusion Radiale EASY-Héparine
Run by Laval University · NCT06981624 · Data updated 2026-11-12
This test compares giving heparin to all patients versus only to selected patients to see which approach better prevents radial artery blockage after diagnostic transradial catheterization.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Laval University Academic / other |
| Locations | 1 site (Québec, Quebec) |
| Status | Recruiting |
| Started | May 13, 2025 |
| Main results expected | August 2026 |
| Study ends | December 2026 |
| Registry record updated | January 26, 2026 |
| Trial ID | NCT06981624 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults referred for diagnostic transradial catheterization who can provide informed consent and can receive antiplatelet therapy and intravenous anticoagulation are ideal candidates.
✕Probably not a fit
Patients who cannot consent, cannot receive antiplatelet or anticoagulant drugs, or who have local access complications such as hematoma or pseudoaneurysm are unlikely to be eligible or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults referred for diagnostic transradial catheterization are randomized to a routine (systematic) heparin strategy or an elective/selective heparin strategy, with hemostasis managed using a dual-artery compression system. The main outcome is occurrence of radial artery occlusion after the procedure. Patients who cannot consent or cannot receive required antiplatelet or anticoagulant medications are excluded. The trial is conducted at a single tertiary cardiac center with follow-up to document artery patency and immediate postprocedural complications.
Why it matters
Potential benefit: If successful, this approach could allow clinicians to avoid unnecessary heparin in some patients while preserving radial artery patency and reducing bleeding risk.
How similar studies have gone: Prior studies have shown routine periprocedural heparin reduces radial artery occlusion, while selective or no-heparin strategies have been less thoroughly tested in randomized comparisons.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any patient referred for a diagnostic transradial catheterism Exclusion Criteria: * Unable to understand study design or provide informed consent * Unable to receive antiplatelet therapy with aspirina and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine * Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access. * Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.
Where it's running
-
Iucpq
Québec, Quebec, Canada Recruiting
Study contacts
- Study coordinator: Michele Jadin
- Email: michele.jadin@criucpq.ulaval.ca
- Phone: 418-656-8711
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Radial and Ulnar Access in Vascular Interventions Registry
This registry tests how often radial or ulnar artery access is used and what happens afterward in routine vascular procedures.
-
Using the ulnar artery when the same-arm radial artery is blocked for heart angiography or angioplasty
This study will try using the ulnar artery in the same arm with a blocked radial artery to see if it's safe and how it affects hand strength, feeling, and everyday hand use in adults having coronary angiography or angioplasty.
-
Best timing for heparin during radial-access coronary procedures
This research will test whether giving heparin before inserting the radial sheath instead of after lowers the chance of radial artery occlusion in adults having radial-access coronary angiography or PCI.
-
Using Rivaroxaban to treat radial artery occlusion after heart procedures
This study is testing if the blood thinner Rivaroxaban can help people with blocked radial arteries after heart procedures feel better and have fewer complications.
-
Using a new device to prevent radial artery occlusion after catheterization
This study is testing a new band to see if it can help prevent blockage in the wrist artery after heart procedures, making it safer and more comfortable for patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.